TR200100629T2 - Mide-bağırsak aktif maddeleri içeren mukozaya yapışan oral bileşimler - Google Patents

Mide-bağırsak aktif maddeleri içeren mukozaya yapışan oral bileşimler

Info

Publication number
TR200100629T2
TR200100629T2 TR2001/00629T TR200100629T TR200100629T2 TR 200100629 T2 TR200100629 T2 TR 200100629T2 TR 2001/00629 T TR2001/00629 T TR 2001/00629T TR 200100629 T TR200100629 T TR 200100629T TR 200100629 T2 TR200100629 T2 TR 200100629T2
Authority
TR
Turkey
Prior art keywords
adhere
component
composition
weight
active substances
Prior art date
Application number
TR2001/00629T
Other languages
English (en)
Inventor
Joseph Dobrozsi Douglas
Ehren Vienneau Todd
Robert Mayer Christopher
Jivanlal Desai Kishorkumar
Original Assignee
The Procter & Gamble Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Procter & Gamble Company filed Critical The Procter & Gamble Company
Publication of TR200100629T2 publication Critical patent/TR200100629T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Mevcut bulus bir mide bagirsak aktif maddesinin güvenli ve etkili bir miktari, bilesimin agirligina göre yaklasik %1.5 ila yaklasik %10 bir kil bileseni, ve bilesimin agirligina göre yaklasik %0.01 ila yaklasik %1 bir reçine bileseni içeren mukozaya yapisan bilesimler ile ilgilidir.Alternatif olarak, kil bileseni bir titanyum oksit veya bir silikon oksit bileseni olabilir. Mukozaya yapisan bilesimler ayrica tercihen bilesimin agirligina göre en çok yaklasik %2 bir iyonik olmayan bilesen örnegin metil selüloz içerir. Mevcut bulus ayrica insanlarda veya daha alt sinif hayvanlarda mide bagirsak sistemi bozukluklarinin mevcut bulusun bir bilesiminin oral olarak uygulanmasiyla önlenmesi ve tedavisi için yöntemlerle de ilgilidir.
TR2001/00629T 1998-08-24 1999-08-24 Mide-bağırsak aktif maddeleri içeren mukozaya yapışan oral bileşimler TR200100629T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9757698P 1998-08-24 1998-08-24

Publications (1)

Publication Number Publication Date
TR200100629T2 true TR200100629T2 (tr) 2001-07-23

Family

ID=22264116

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/00629T TR200100629T2 (tr) 1998-08-24 1999-08-24 Mide-bağırsak aktif maddeleri içeren mukozaya yapışan oral bileşimler

Country Status (15)

Country Link
US (1) US20010016577A1 (tr)
EP (1) EP1115378A1 (tr)
JP (1) JP2002523352A (tr)
KR (1) KR20010072463A (tr)
CN (1) CN1313755A (tr)
AU (1) AU5685299A (tr)
BR (1) BR9913227A (tr)
CA (1) CA2338688A1 (tr)
CO (1) CO5140071A1 (tr)
HU (1) HUP0103216A2 (tr)
ID (1) ID27728A (tr)
NO (1) NO20010833L (tr)
PE (1) PE20000860A1 (tr)
TR (1) TR200100629T2 (tr)
WO (1) WO2000010527A1 (tr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2801791B1 (fr) * 1999-12-03 2003-05-30 Elpronat Composition pour animaux contenant du salicylate de methyle
SI1474109T1 (sl) 2001-12-21 2010-11-30 Alcon Inc Uporaba sintetičnih anorganskih nanodelcev kot nosilcev za oftalmična zdravila
JP4513007B2 (ja) * 2002-09-26 2010-07-28 アステラス製薬株式会社 薬物吸収性改善剤
US8324192B2 (en) 2005-11-12 2012-12-04 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8679545B2 (en) 2005-11-12 2014-03-25 The Regents Of The University Of California Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US20090123390A1 (en) * 2007-11-13 2009-05-14 Meritage Pharma, Inc. Compositions for the treatment of gastrointestinal inflammation
US20100216754A1 (en) * 2007-11-13 2010-08-26 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
CA2704946C (en) 2007-11-13 2013-09-24 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
DE102008019339A1 (de) * 2008-04-16 2009-10-22 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung für die medizinische Anwendung, insbesondere Antazidum
WO2011017489A1 (en) * 2009-08-05 2011-02-10 Tyco Healthcare Group Lp Surgical wound dressing incorporating connected hydrogel beads having an embedded electrode therein
EP2386289A1 (en) * 2010-04-29 2011-11-16 Ipsen Pharma S.A.S. Clay compositions
EP2654673A1 (en) * 2010-12-23 2013-10-30 Colgate-Palmolive Company Fluid compositions comprising a structuring agent
CN107648070A (zh) 2011-12-15 2018-02-02 高露洁-棕榄公司 水性口腔护理组合物
US20140178456A1 (en) * 2012-08-30 2014-06-26 Udaya Sankar Devanaboyina Methods and compositions for treating type 2 diabetes and related conditions
MX349983B (es) 2012-12-03 2017-08-23 Colgate Palmolive Co Procesos de fabricacion para geles de fluido.
US11931227B2 (en) 2013-03-15 2024-03-19 Cook Medical Technologies Llc Bimodal treatment methods and compositions for gastrointestinal lesions with active bleeding
US9486460B2 (en) * 2014-04-29 2016-11-08 The Procter & Gamble Company Bismuth containing liquid pharmaceutical suspensions
MX370908B (es) * 2014-04-29 2020-01-08 Procter & Gamble Metodo para fabricar suspensiones farmaceuticas liquidas que contienen bismuto.
EP3169374B1 (en) 2014-07-14 2022-01-05 University of Utah Research Foundation In situ solidifying complex coacervates and methods of making and using thereof
JP2017178881A (ja) * 2016-03-31 2017-10-05 小林製薬株式会社 経口組成物
JP6950312B2 (ja) * 2017-07-12 2021-10-13 ライオン株式会社 液体医薬組成物及び医薬品
JP2019064980A (ja) * 2017-10-03 2019-04-25 小林製薬株式会社 逆流性食道炎改善剤
WO2019147922A2 (en) 2018-01-26 2019-08-01 Fluidx Medical Technology, Llc Apparatus and method of using in situ solidifying complex coacervates for vascular occlusion

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5296241A (en) * 1991-04-03 1994-03-22 Brimberg Barnett J Therapeutic composition and method of using same for treatment of hangover
GB9114950D0 (en) * 1991-07-11 1991-08-28 Smithkline Beecham Plc Pharmaceutical formulation
WO1994020074A1 (en) * 1993-03-12 1994-09-15 The Procter & Gamble Company Adsorbate compositions

Also Published As

Publication number Publication date
KR20010072463A (ko) 2001-07-31
CO5140071A1 (es) 2002-03-22
PE20000860A1 (es) 2000-09-11
CA2338688A1 (en) 2000-03-02
BR9913227A (pt) 2001-05-22
EP1115378A1 (en) 2001-07-18
US20010016577A1 (en) 2001-08-23
CN1313755A (zh) 2001-09-19
WO2000010527A1 (en) 2000-03-02
NO20010833D0 (no) 2001-02-19
JP2002523352A (ja) 2002-07-30
HUP0103216A2 (hu) 2002-01-28
ID27728A (id) 2001-04-26
NO20010833L (no) 2001-02-19
AU5685299A (en) 2000-03-14

Similar Documents

Publication Publication Date Title
TR200100629T2 (tr) Mide-bağırsak aktif maddeleri içeren mukozaya yapışan oral bileşimler
TR200100628T2 (tr) Mukozaya yapışan (muko-adhesif) oral sıvı bileşimler.
TR200100569T2 (tr) Mukozaya yapışan (muko-adhesif) oral sıvı bileşimler
DE69934135D1 (de) Dosierungsformen enthaltend geschmacksmaskierten wirkstoffen
CY1115766T1 (el) Καθαρισμος και σταθεροποιηση πεπτιδιου και πρωτεϊνων σε φαρμακευτικους παραγοντες
DK1121103T3 (da) Oralt disintegrerbare tabletter, der omfatter en benzimidazol
DE60233967D1 (de) Verbesserte essbare filmformulierungen mit maltodextrin
NO20015782L (no) Kostblanding eller farmasöytisk sammensetning til anvendelse for forebyggelse eller behandling av hyperoksaluri
DE60204058D1 (de) Netzwerk-bildende und pektin-enthaltende zubereitung
SE456135B (sv) Lekemedelspreparat med antinikotinverkan och forfarande for framstellning derav
RU97110066A (ru) Содержащие ондансетрон составы для перорального введения
NL300428I1 (nl) Fosfaat bindende polymeren voor orale toediening
BR0107147A (pt) Composições farmacêuticas de drogas anti-tuberculosas e processo para as suas preparações
FI964332A (fi) Eräiden metaanibisfosfonihappojohdannaisten käyttö proteesin löystymisen ja proteesin vaelluksen estämiseen
DE69806801D1 (de) Galenische präparation zur prävention und behandlung von hepatokarzinomen
ATE106737T1 (de) Pharmazeutische zusammensetzungen zur behandlung gastrointestinaler störungen.
EP1123696A4 (en) COMPOSITIONS FOR ORAL CAVITY
IS4553A (is) Lyfjablöndur sem innihalda mónóamín oxídasa B blokkara
ATE315399T1 (de) Hemmung von systemischen infektionen in menschen und wirbeltieren mit ballaststoffen
DE69804865T2 (de) Feste miltefosin enthaltende arzneimittel zur oralen verabreichung bei der behandlung von leishmaniasis
ATE56148T1 (de) Orales dextran enthaltende zusammensetzungen.
TR200100566T2 (tr) Mukozaya yapışan(muko-adhesif)oral sıvı bileşimler
EA200000568A3 (ru) Применение мелатонинергических лигандов для получения фармацевтических композиций, предназначенных для профилактики или лечения патологий желудочно-кишечной системы
ATE468130T1 (de) Inhibitoren der kostimulation via ox40 und deren verwendung gegen eine von virusen induzierten immunpathologie
FR2719480B1 (fr) Compositions pharmaceutiques destinées à prévenir et/ou traiter l'expression du comportement de couvaison chez les oiseaux et plus particulièrement chez la dinde et leurs procédés de préparation.